Company / EPS (Diluted)
Aquestive Therapeutics, Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.51
FY2025
5-year range
-$1.85 / -$0.13
FY2021-FY2025
Trend
-292.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -292% YoY in FY2025, a notable deviation from the 7-year average annual change of -189%.
Based on SEC 10-K filings.
-0.51 in FY2025.
Improved from $-1.12 to $-0.51 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 292.3% year-over-year.
- Peak eps (diluted) was recorded in FY2018.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.51 | -292.3% |
| FY2024 | -$0.13 | +88.4% |
| FY2023 | -$1.12 | +39.5% |
| FY2022 | -$1.85 | -11.4% |
| FY2021 | -$1.66 | +36.4% |
| FY2020 | -$2.61 | +11.8% |
| FY2019 | -$2.96 | -1196.3% |
| FY2018 | $0.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026